iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Narrative) (Details)

Stockholders' Equity (Narrative) (Details)								3 Months Ended	9 Months Ended
Stockholders' Equity (Narrative) (Details)	Nov. 27, 2023	Oct. 01, 2023 shares	Oct. 07, 2022	Sep. 22, 2022	May 09, 2022 USD ($) $ / shares shares	Oct. 31, 2021 $ / shares	Feb. 23, 2017 USD ($) shares	Mar. 31, 2024 USD ($) $ / shares shares	Mar. 31, 2024 $ / shares shares	Mar. 26, 2024 $ / shares	Aug. 04, 2023 $ / shares shares	Aug. 03, 2023 $ / shares	Jun. 30, 2023 $ / shares shares	Dec. 06, 2022 shares	Jul. 19, 2022 shares	Nov. 01, 2021 $ / shares shares
Stockholders' Equity [Line Items]
Preferred Stock, shares authorized								1,000,000	1,000,000				1,000,000
Preferred stock, shares outstanding (in shares)								0	0				0
Preferred stock, par value (in dollars per share) \| $ / shares								$ 0.001	$ 0.001				$ 0.001
Common stock, shares authorized (in shares)								275,000,000	275,000,000				275,000,000
Common stock, par value (in dollars per share) \| $ / shares								$ 0.001	$ 0.001				$ 0.001
Warrants, exercise price per share \| $ / shares										$ 0.0001
Proceeds from exercise of warrants \| $								$ 4,276,000
Reverse stock split, shares received per share tendered	0.05		0.04	0.04
Maximum [Member]
Stockholders' Equity [Line Items]
Reverse stock split, shares received per share tendered	0.2
Minimum [Member]
Stockholders' Equity [Line Items]
Reverse stock split, shares received per share tendered	0.05
College Station Investors LLC And Bryan Capital
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares																$ 665
Warrants to purchase shares of Common Stock																2,579
Representative Warrants
Stockholders' Equity [Line Items]
Exercise of warrants (in shares)								0	0
Warrants to purchase shares of Common Stock														10,096
Pre Funded Warrants \| Representative Warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares								$ 0.001	$ 0.001
Series A warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares											$ 10.00	$ 20.80
Warrants to purchase shares of Common Stock											173,795
Series A warrants \| Representative Warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares								$ 20.80	$ 20.80
Term of the warrants								5 years	5 years
Warrants to purchase shares of Common Stock														25,240
Series B warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares											$ 10.00	$ 20.80
Warrants to purchase shares of Common Stock											102,900
Series B warrants \| Representative Warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares								$ 20.80	$ 20.80
Term of the warrants								2 years	2 years
Warrants to purchase shares of Common Stock														25,240
Representative Warrants \| Representative Warrants
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares								$ 26.00	$ 26.00
Term of the warrants								5 years	5 years
iBio CMO Preferred Tracking Stock
Stockholders' Equity [Line Items]
Preferential dividend rate percentage							2.00%
Preferred Stock, Dividends Per Share, Declared \| $ / shares						$ 0
Preferred stock, shares outstanding (in shares)																0
Series 2022 Convertible Preferred Stock
Stockholders' Equity [Line Items]
Proceeds from sale of shares, net of issuance cost \| $					$ 270
Shares issued upon conversion															2
Preferred stock, par value (in dollars per share) \| $ / shares					$ 0.001
Shares issued					1,000
Reverse stock split, shares received per share tendered					1
Exchange Agreement \| iBio CMO Preferred Tracking Stock \| Bioprocessing (iBio CDMO)
Stockholders' Equity [Line Items]
Stock issued during period, shares, acquisitions							1
Number of LLC interest units exchanged for each share of preferred tracking stock							29,990,000
Proceeds from sale of shares, net of issuance cost \| $							$ 13,000,000
Exchange Agreement \| iBio CMO Preferred Tracking Stock \| After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests \| Bioprocessing (iBio CDMO)
Stockholders' Equity [Line Items]
Noncontrolling interest, ownership percentage by parent							99.99%
Exchange Agreement \| iBio CMO Preferred Tracking Stock \| Eastern Affiliate \| After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests \| Bioprocessing (iBio CDMO)
Stockholders' Equity [Line Items]
Noncontrolling interest, ownership percentage by noncontrolling owners							0.01%
Lincoln Park Purchase Agreement
Stockholders' Equity [Line Items]
Shares issued		21,457							181,141